Dynamic Technology Lab Private LTD Intellia Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $218,178 - $315,882	6,900 Added 128.25%	12,280 $388,000
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $186,040 - $247,641	5,380 New	5,380 $219,000
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $438,369 - $582,921	8,130 New	8,130 $455,000
Q2 2022 Aug 12, 2022	SELL	$38.49 - $76.21 $133,560 - $264,448	-3,470 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $202,196 - $412,895	3,470 New	3,470 $252,000
Q3 2017 Nov 08, 2017	SELL	$15.16 - $25.75 $158,482 - $269,190	-10,454 Closed	0 $0
Q2 2017 Aug 17, 2017	BUY	N/A	10,454	10,454 $167,000

313

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $929M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.